Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 2Vomiting 1Vascular Malformations 1Resectable Pancreatic Ductal Adenocarcinoma 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Postoperative Complications 1Neoplasms 1Nausea 1Myofibroma 1Myasthenia Gravis 1Microbiota 1Melanoma 1Lymphangioma 1Leiomyoma 1Hepatitis B 1Hand-Foot Skin Reaction (HFSR) 1Glioblastoma 1Erectile Dysfunction 1Carcinoma, Non-Small-Cell Lung 1Blood Loss, Surgical 1

Interventions

entecavir 4bicyclol 1adefovir 1Tenofovir 1Telbivudine 1Tablets 1Radiomics 1Radiofrequency Ablation 1Nucleosides 1Lamivudine 1Interferons 1Cyclophosphamide 1Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hepatitis B × Tablets × Clear all
NCT03680183 2018-09-28

Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

Unknown
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡